Clear Harbor Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.76M | Buy |
29,013
+8,307
| +40% | +$484K | 0.12% | 140 |
|
|
2025
Q4 | $1.12M | Sell |
20,706
-25
| -0.1% | -$1.2K | 0.08% | 185 |
|
|
2025
Q3 | $935K | Sell |
20,731
-730
| -3% | -$34.1K | 0.06% | 202 |
|
|
2025
Q2 | $993K | Sell |
21,461
-1,312
| -6% | -$64.4K | 0.07% | 179 |
|
|
2025
Q1 | $1.39M | Sell |
22,773
-1,407
| -6% | -$82K | 0.11% | 137 |
|
|
2024
Q4 | $1.37M | Sell |
24,180
-1,506
| -6% | -$84.1K | 0.11% | 139 |
|
|
2024
Q3 | $1.33M | Buy |
25,686
+10,520
| +69% | +$494K | 0.11% | 138 |
|
|
2024
Q2 | $630K | Sell |
15,166
-240
| -2% | -$10.7K | 0.05% | 199 |
|
|
2024
Q1 | $835K | Sell |
15,406
-2,832
| -16% | -$144K | 0.07% | 169 |
|
|
2023
Q4 | $936K | Buy |
18,238
+297
| +2% | +$15.6K | 0.09% | 157 |
|
|
2023
Q3 | $1.04M | Sell |
17,941
-2,119
| -11% | -$130K | 0.11% | 138 |
|
|
2023
Q2 | $1.28M | Sell |
20,060
-14,651
| -42% | -$982K | 0.13% | 130 |
|
|
2023
Q1 | $2.41M | Buy |
34,711
+7,363
| +27% | +$519K | 0.25% | 89 |
|
|
2022
Q4 | $1.97M | Buy |
27,348
+1,708
| +7% | +$129K | 0.25% | 83 |
|
|
2022
Q3 | $1.82M | Hold |
25,640
| – | – | 0.25% | 75 |
|
|
2022
Q2 | $1.97M | Sell |
25,640
-16,931
| -40% | -$1.29M | 0.26% | 74 |
|
|
2022
Q1 | $3.11M | Sell |
42,571
-12,920
| -23% | -$868K | 0.35% | 58 |
|
|
2021
Q4 | $3.46M | Sell |
55,491
-26,620
| -32% | -$1.56M | 0.38% | 50 |
|
|
2021
Q3 | $4.86M | Buy |
82,111
+15,481
| +23% | +$1.02M | 0.09% | 46 |
|
|
2021
Q2 | $4.45M | Sell |
66,630
-8,784
| -12% | -$573K | 0.54% | 34 |
|
|
2021
Q1 | $4.76M | Buy |
75,414
+41,823
| +125% | +$2.6M | 0.62% | 30 |
|
|
2020
Q4 | $2.08M | Buy |
33,591
+2,440
| +8% | +$150K | 0.3% | 59 |
|
|
2020
Q3 | $1.88M | Buy |
31,151
+1,959
| +7% | +$118K | 0.32% | 60 |
|
|
2020
Q2 | $1.72M | Buy |
29,192
+5,489
| +23% | +$328K | 0.32% | 61 |
|
|
2020
Q1 | $1.32M | Buy |
23,703
+10,315
| +77% | +$630K | 0.31% | 63 |
|
|
2019
Q4 | $859K | Buy |
13,388
+597
| +5% | +$34.2K | 0.15% | 109 |
|
|
2019
Q3 | $649K | Buy |
12,791
+4,554
| +55% | +$214K | 0.13% | 118 |
|
|
2019
Q2 | $374K | Sell |
8,237
-1,400
| -15% | -$65.2K | 0.08% | 165 |
|
|
2019
Q1 | $460K | Buy |
9,637
+229
| +2% | +$11.4K | 0.09% | 149 |
|
|
2018
Q4 | $489K | Buy |
9,408
+1,500
| +19% | +$80.6K | 0.11% | 131 |
|
|
2018
Q3 | $389K | Hold |
7,908
| – | – | 0.08% | 163 |
|
|
2018
Q2 | $438K | Hold |
7,908
| – | – | 0.08% | 154 |
|
|
2018
Q1 | $500K | Buy |
7,908
+171
| +2% | +$11K | 0.1% | 130 |
|
|
2017
Q4 | $474K | Buy |
7,737
+500
| +7% | +$31.3K | 0.09% | 140 |
|
|
2017
Q3 | $461K | Hold |
7,237
| – | – | 0.09% | 152 |
|
|
2017
Q2 | $398K | Sell |
7,237
-100
| -1% | -$5.44K | 0.08% | 162 |
|
|
2017
Q1 | $399K | Sell |
7,337
-250
| -3% | -$13.7K | 0.08% | 168 |
|
|
2016
Q4 | $443K | Hold |
7,587
| – | – | 0.09% | 147 |
|
|
2016
Q3 | $409K | Buy |
7,587
+100
| +1% | +$6.42K | 0.09% | 156 |
|
|
2016
Q2 | $551K | Sell |
7,487
-34
| -0.5% | -$2.4K | 0.12% | 127 |
|
|
2016
Q1 | $480K | Hold |
7,521
| – | – | 0.11% | 135 |
|
|
2015
Q4 | $517K | Hold |
7,521
| – | – | 0.12% | 132 |
|
|
2015
Q3 | $445K | Hold |
7,521
| – | – | 0.1% | 158 |
|
|
2015
Q2 | $500K | Buy |
7,521
+48
| +0.6% | +$3.16K | 0.1% | 163 |
|
|
2015
Q1 | $482K | Sell |
7,473
-600
| -7% | -$37.6K | 0.09% | 171 |
|
|
2014
Q4 | $477K | Hold |
8,073
| – | – | 0.1% | 167 |
|
|
2014
Q3 | $413K | Sell |
8,073
-300
| -4% | -$15K | 0.09% | 145 |
|
|
2014
Q2 | $406K | Sell |
8,373
-100
| -1% | -$4.93K | 0.09% | 148 |
|
|
2014
Q1 | $440K | Hold |
8,473
| – | – | 0.1% | 143 |
|
|
2013
Q4 | $450K | Buy |
8,473
+74
| +0.9% | +$3.77K | 0.11% | 124 |
|
|
2013
Q3 | $389K | Buy |
8,399
+75
| +0.9% | +$3.29K | 0.11% | 120 |
|
|
2013
Q2 | $372K | Buy |
+8,324
| New | +$361K | 0.11% | 122 |
|
Other funds holding BMY
VCM
VPM
Clear Harbor Asset Management's BMY Position: Q1 2026 in Review
Clear Harbor Asset Management increased its Bristol-Myers Squibb (BMY) stake by 40% in Q1 2026, buying an estimated $484K and bringing the position to 29,013 shares worth $1.76M. The position accounts for 0.12% of the portfolio, ranked #140.
Clear Harbor Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.86M in Q3 2021. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Clear Harbor Asset Management held 29,013 shares of Bristol-Myers Squibb worth $1.76M as of Q1 2026.
- Clear Harbor Asset Management bought 8,307 Bristol-Myers Squibb shares in Q1 2026, an estimated $484K.
- Bristol-Myers Squibb made up 0.12% of Clear Harbor Asset Management's portfolio in Q1 2026, its #140 holding.
- Clear Harbor Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Clear Harbor Asset Management's Bristol-Myers Squibb position peaked at $4.86M in Q3 2021.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.